Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Dec 2020| TBR522C| TBRC (Publisher)

Report Highlights

Including: By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others
By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma
By Prescription Type: OTC Drugs; Prescription Drugs

Covering: Allergen Plc.; Novartis AG; Santen Pharmaceutical Co., Ltd.; Akorn; Pfizer

Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the antiglaucoma drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global antiglaucoma drugs market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by product type, by condition type and segmentation by prescription type.
  • Market Characteristics – The market characteristics section of the report defines and explains the antiglaucoma drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global antiglaucoma drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the antiglaucoma drugs market.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global antiglaucoma drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Pipeline Analysis – This section gives brief idea on antiglaucoma drugs in pipeline.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for antiglaucoma drugs companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global Antiglaucoma Drugs market is segmented into -

By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others
By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma
By Prescription Type: OTC Drugs; Prescription Drugs

Companies Mentioned: Allergen Plc.; Novartis AG; Santen Pharmaceutical Co., Ltd.; Akorn; Pfizer

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

  • Table 1 : Global Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 2 : Global Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 3 : Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 4 : Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5 : Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 6 : Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 7 : Global Antiglaucoma Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 8 : Global Antiglaucoma Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9 : Global Antiglaucoma Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 10 : Global Antiglaucoma Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11 : Global Antiglaucoma Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 12 : Global Antiglaucoma Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 13 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 14 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 15 : Asia Pacific GDP Per Capita, 2015-2019, $
  • Table 16 : Asia Pacific Glaucoma Prevalence, 2015-2019
  • Table 17 : Asia-Pacific Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 18 : Asia-Pacific Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 19 : Asia-Pacific Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 20 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 21 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 22 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 23 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 24 : China Population By Age Group, 2015-2023, Thousands
  • Table 25 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 26 : China GDP Per Capita, 2015-2019, $
  • Table 27 : China Glaucoma Prevalence, 2015-2019
  • Table 28 : China Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 29 : China Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 30 : China Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 31 : China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 32 : China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 33 : China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 34 : China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 35 : India Population By Age Group, 2015-2023, Thousands
  • Table 36 : India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 37 : India GDP Per Capita, 2015-2019, $
  • Table 38 : India Glaucoma Prevalence, 2015-2019
  • Table 39 : India Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 40 : India Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 41 : India Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 42 : India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 43 : India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44 : India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 45 : India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 46 : Japan Population By Age Group, 2015-2023, Thousands
  • Table 47 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 48 : Japan GDP Per Capita, 2015-2019, $
  • Table 49 : Japan Glaucoma Prevalence, 2015-2019
  • Table 50 : Japan Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 51 : Japan Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 52 : Japan Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 53 : Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 54 : Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 55 : Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 56 : Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 57 : Australia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 58 : Australia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 59 : Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 60 : Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 61 : Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 62 : Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 63 : Indonesia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 64 : Indonesia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 65 : Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 66 : Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 67 : Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 68 : Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 69 : South Korea Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 70 : South Korea Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 71 : South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 72 : South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 73 : South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 74 : South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 75 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 76 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 77 : Western Europe GDP Per Capita, 2015-2019, $
  • Table 78 : Western Europe Glaucoma Prevalence, 2015-2019
  • Table 79 : Western Europe Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 80 : Taxes Levied On Prescription Drugs In Western European Countries, %
  • Table 81 : Western Europe Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 82 : Western Europe Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 83 : Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 84 : Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 85 : Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 86 : Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 87 : UK Population By Age Group, 2015-2023, Thousands
  • Table 88 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 89 : UK GDP Per Capita, 2015-2019, $
  • Table 90 : UK Glaucoma Prevalence, 2015-2019
  • Table 91 : UK Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 92 : UK Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 93 : UK Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 94 : UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 95 : UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 96 : UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 97 : UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 98 : Germany Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 99 : Germany Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 100 : Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 101 : Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 102 : Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 103 : Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 104 : France Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 105 : France Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 106 : France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 107 : France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 108 : France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 109 : France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 110 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 111 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 112 : Eastern Europe GDP Per Capita, 2015-2019, $
  • Table 113 : Eastern Europe Glaucoma Prevalence, 2015-2019
  • Table 114 : Eastern Europe Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 115 : Eastern Europe Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 116 : Eastern Europe Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 117 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 118 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 119 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 120 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 121 : Russia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 122 : Russia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 123 : Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 124 : Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 125 : Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 126 : Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 127 : North America Population By Age Group, 2015-2023, Thousands
  • Table 128 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 129 : North America GDP Per Capita, 2015-2019, $
  • Table 130 : North America Glaucoma Prevalence, 2015-2019
  • Table 131 : North America Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 132 : North America Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 133 : North America Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 134 : North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 135 : North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136 : North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 137 : North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 138 : USA Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market, Population By Age Group, 2015-2023, Thousands
  • Table 139 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 140 : USA GDP Per Capita, 2015-2019, $
  • Table 141 : USA Glaucoma Prevalence, 2015-2019
  • Table 142 : USA Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 143 : USA Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 144 : USA Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 145 : USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 146 : USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 147 : USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 148 : USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 149 : South America Population By Age Group, 2015-2023, Thousands
  • Table 150 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 151 : South America GDP Per Capita, 2015-2019, $
  • Table 152 : South America Glaucoma Prevalence, 2015-2019
  • Table 153 : South America Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 154 : South America Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 155 : South America Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 156 : South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 157 : South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 158 : South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 159 : South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160 : Brazil Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 161 : Brazil Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 162 : Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 163 : Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 164 : Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 165 : Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 166 : Middle East Population By Age Group, 2015-2023, Thousands
  • Table 167 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 168 : Middle East GDP Per Capita, 2015-2019, $
  • Table 169 : Middle East Glaucoma Prevalence, 2015-2019
  • Table 170 : Middle East Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 171 : Middle East Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 172 : Middle East Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 173 : Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 174 : Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 175 : Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 176 : Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 177 : Africa Population By Age Group, 2015-2023, Thousands
  • Table 178 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 179 : Africa GDP Per Capita, 2015-2019, $
  • Table 180 : Africa Glaucoma Prevalence, 2015-2019
  • Table 181 : Africa Ophthalmic Devices Market Size, 2015-2019, $ Billion
  • Table 182 : Africa Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Table 183 : Africa Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 184 : Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 185 : Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 186 : Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 187 : Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 188 : Global Antiglaucoma Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 189 : Allergen Plc. - Financial Performance, 2015 - 2019, $ Billion
  • Table 190 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Table 191 : Santen Pharmaceutical Co., Ltd.- Financial Performance, 2015 - 2019, $ Billion
  • Table 192 : Akorn- Financial Performance, 2015-2019, $ Billion
  • Table 193 : Pfizer- Financial Performance, 2015 - 2019, $ Billion
  • Table 194 : Global Antiglaucoma Drugs Market, Pipeline Analysis
  • Table 195 : Global Antiglaucoma Drugs Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 196 : Global Antiglaucoma Drugs Market Size Gain ($ Million), Segmentation By Product type , 2019 - 2023
  • Table 197 : Global Antiglaucoma Drugs Market Size Gain ($ Million), Segmentation By Condition Type , 2019 - 2023
  • Table 198 : Global Antiglaucoma Drugs Market Size Gain ($ Million), Segmentation By Prescription Type , 2019 - 2023
  • Table 199 : Antiglaucoma Drugs - Market Data Sources
  • Figure 1 : Global Antiglaucoma Drugs Market Segmentation By Product Type
  • Figure 2 : Global Antiglaucoma Drugs Market Segmentation By Condition Type
  • Figure 3 : Global Antiglaucoma Drugs Market Segmentation, By Prescription Type
  • Figure 4 : Global Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 5 : Global Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 6 : Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 7 : Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 8 : Global Antiglaucoma Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 9 : Global Antiglaucoma Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 10 : Global Antiglaucoma Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 11 : Asia-Pacific Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 12 : Asia-Pacific Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 13 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 14 : Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 15 : China Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 16 : China Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 17 : China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 18 : China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 19 : India Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 20 : India Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 21 : India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 22 : India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 23 : Japan Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 24 : Japan Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 25 : Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26 : Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 27 : Australia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 28 : Australia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 29 : Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 30 : Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 31 : Indonesia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 32 : Indonesia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 33 : Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 34 : Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 35 : South Korea Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 36 : South Korea Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 37 : South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 38 : South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 39 : Western Europe Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 40 : Western Europe Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 41 : Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 42 : Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 43 : UK Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 44 : UK Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 45 : UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 46 : UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 47 : Germany Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 48 : Germany Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 49 : Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 50 : Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 51 : France Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 52 : France Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 53 : France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 54 : France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 55 : Eastern Europe Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 56 : Eastern Europe Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 57 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 58 : Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 59 : Russia Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 60 : Russia Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 61 : Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 62 : Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 63 : North America Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 64 : North America Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 65 : North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 66 : North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 67 : USA Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 68 : USA Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 69 : USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 70 : USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 71 : South America Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 72 : South America Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 73 : South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 74 : South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 75 : Brazil Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 76 : Brazil Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 77 : Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 78 : Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 79 : Middle East Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 80 : Middle East Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 81 : Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 82 : Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 83 : Africa Antiglaucoma Drugs Market, Historic, 2015 - 2019, $ Million
  • Figure 84 : Africa Antiglaucoma Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 85 : Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 86 : Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 87 : Global Antiglaucoma Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 88 : Allergen Plc. - Financial Performance, 2015 - 2019, $ Billion
  • Figure 89 : Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 90 : Santen Pharmaceutical Co., Ltd.- Financial Performance, 2015 - 2019, $ Billion
  • Figure 91 : Akorn- Financial Performance, 2015-2019, $ Billion
  • Figure 92 : Pfizer- Financial Performance, 2015 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report